Response to Patoulias et al. letter regarding article “Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial”

Jesper Jensen; Massar Omar; Jacob Eifer Møller; Morten Schou

doi:10.1016/j.ahj.2021.02.007

Response to Patoulias et al. letter regarding article “Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial”

Jesper Jensen^*, Massar Omar, Jacob Eifer Møller, Morten Schou

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	American Heart Journal
Vol/bind	236
Sider (fra-til)	106
Antal sider	1
ISSN	0002-8703
DOI	https://doi.org/10.1016/j.ahj.2021.02.007
Status	Udgivet - 2021

Adgang til dokumentet

10.1016/j.ahj.2021.02.007

Citationsformater

Response to Patoulias et al. letter regarding article “Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction : A double-blinded, randomized, and placebo-controlled trial”. / Jensen, Jesper; Omar, Massar; Møller, Jacob Eifer; Schou, Morten.

I: American Heart Journal, Bind 236, 2021, s. 106.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

@article{931978c9e01d45a1a72fb982410be028,

title = "Response to Patoulias et al. letter regarding article “Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial”",

author = "Jesper Jensen and Massar Omar and M{\o}ller, {Jacob Eifer} and Morten Schou",

year = "2021",

doi = "10.1016/j.ahj.2021.02.007",

language = "English",

volume = "236",

pages = "106",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Response to Patoulias et al. letter regarding article “Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction

T2 - A double-blinded, randomized, and placebo-controlled trial”

AU - Jensen, Jesper

AU - Omar, Massar

AU - Møller, Jacob Eifer

AU - Schou, Morten

PY - 2021

Y1 - 2021

U2 - 10.1016/j.ahj.2021.02.007

DO - 10.1016/j.ahj.2021.02.007

M3 - Comment/debate

C2 - 33902821

AN - SCOPUS:85104677699

VL - 236

SP - 106

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

ER -